S133: AN ENTIRELY ORAL REGIMEN OF ORAL-ATO, ATRA AND ASCORBIC ACID IN RISK-ADAPTED TREATMENT OF NEWLY-DIAGNOSED APL RESULTED IN EXCELLENT CLINICAL/MOLECULAR RESPONSES WITH DURABLE...

por Gill, Harry, Yim, Rita, Chin, Lynn, Lee, Paul, LI, Vivian, Au, Lester, Kit Garret Leung, Man, Kumana, Cyrus, Lam Kwong, Yok
Publicado 2023

P493: ORAL-ATO/ATRA/ASCORBIC ACID (AAA)-BASED INDUCTION OR MAINTENANCE OF FIRST COMPLETE REMISSION IMPROVED OUTCOMES IN NEWLY DIAGNOSED APL: A MULTICENTRE ANALYSIS OF THE APL ASIAN...

por Gill, Harry, Raghupathy, Radha, Hou, Hsin-An, Tantiworawit, Adisak, Ooi, Melissa G., Chia, Priscella S., Gin Gan, Gin, Wong, Chieh-Lee, Chin, Lynn, Yim, Rita, Lee, Paul, Au, Lester, LI, Vivian, Kit Garret Leung, Man, Joo Chng, Wee, Chien Chou, Wen, Tien, Hwei-Fang, Kumana, Cyrus, Lam Kwong, Yok
Publicado 2023